Kistler-Tiffany Companies’s Quest Diagnostics DGX Stock Holding History

Kistler-Tiffany Companies’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$13.2K	Hold	94	–	–	﹤0.01%	669
2023 Q1	$13.3K	Hold	94	–	–	﹤0.01%	601
2022 Q4	$14.7K	Hold	94	–	–	﹤0.01%	579
2022 Q3	$12K	Hold	94	–	–	﹤0.01%	572
2022 Q2	$13K	Hold	94	–	–	﹤0.01%	557
2022 Q1	$13K	Hold	94	–	–	﹤0.01%	567
2021 Q4	$16K	Hold	94	–	–	﹤0.01%	535
2021 Q3	$14K	Hold	94	–	–	﹤0.01%	542
2021 Q2	$12K	Hold	94	–	–	﹤0.01%	539
2021 Q1	$12K	Hold	94	–	–	﹤0.01%	504
2020 Q4	$11K	Hold	94	–	–	﹤0.01%	490
2020 Q3	$11K	Hold	94	–	–	﹤0.01%	462
2020 Q2	$11K	Hold	94	–	–	﹤0.01%	435
2020 Q1	$10K	Hold	94	–	–	﹤0.01%	434
2019 Q4	$10K	Hold	94	–	–	﹤0.01%	441
2019 Q3	$10K	Hold	94	–	–	﹤0.01%	445
2019 Q2	$10K	Buy	+94	New	+$9.03K	﹤0.01%	437

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kistler-Tiffany Companies's DGX Position: Q2 2023 in Review

Kistler-Tiffany Companies held its Quest Diagnostics (DGX) position steady in Q2 2023 at 94 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #669.

Kistler-Tiffany Companies first reported a position in DGX in Q2 2019 and has held it in 17 quarters since. The position peaked at $16K in Q4 2021. 820 funds tracked by Wall St. Rank hold DGX as of Q2 2023.

Kistler-Tiffany Companies held 94 shares of Quest Diagnostics worth $13.2K as of Q2 2023.
Kistler-Tiffany Companies left its Quest Diagnostics share count unchanged in Q2 2023.
Quest Diagnostics made up ﹤0.01% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #669 holding.
Kistler-Tiffany Companies first reported a position in Quest Diagnostics in Q2 2019 and has held it in 17 quarters since.
Kistler-Tiffany Companies's Quest Diagnostics position peaked at $16K in Q4 2021.
820 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.